Rapalogix Health, Inc.
through Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jun 4, 2025 · D/A | Jun 26, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $13,500,000 | $24,999,999 | $11,499,999 |
| Reported amount sold | $9,079,616 | $19,112,746 | $10,033,130 |
| Reported investor count | — | 28 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002008372-25-000002 · Later SEC source: 0002008372-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $24,999,999
- Reported amount sold
- $19,112,746
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002008372-26-000002D · Jun 26, 2026 · BiotechnologyOffering: $24,999,999Sold: $19,112,746
-
0002008372-25-000002D/A · Jun 4, 2025 · BiotechnologyOffering: $13,500,000Sold: $9,079,616